文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

胸腺醌与阿霉素对人卵巢腺癌细胞系OVCAR3中EGFR/FOXP3信号通路影响的研究

Investigation of the effect of thymoquinone and doxorubicin on the EGFR/FOXP3 signaling pathway in OVCAR3 human ovarian adenocarcinoma cells.

作者信息

Özdemir İlhan, Aktaş Ayfer Şanli, Tuncer Mehmet Cudi

机构信息

Atatürk University - Faculty of Medicine - Department of Gynecology and Obstetrics - Erzurum - Turkey.

Dicle University - Faculty of Medicine - Department of Histology and Embryology - Diyarbakir - Turkey.

出版信息

Acta Cir Bras. 2025 Mar 31;40:e401725. doi: 10.1590/acb401725. eCollection 2025.

DOI:10.1590/acb401725
PMID:40172364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11960576/
Abstract

PURPOSE: To investigate the cytotoxic and apoptotic effects of the combination of doxorubicin (Dox) and thymoquinone (TQ) on ovarian adenocarcinoma cells (OVCAR3) via the EGFR/FOXP3 signaling pathway. METHODS: We used human OVCAR3 and human skin keratinocyte cells (HaCaT). Different concentrations of TQ and Dox were applied to the cells for 24, 48, and 72 hours, and the cytotoxicity level was determined via the MTT method. Expression levels of EGFR/FOXP3 for cell proliferation and apoptosis were determined by quantitative reverse transcription polymerase chain reaction (RT-qPCR) and Western blot analysis. The colony counting was performed after DAPI staining, and the effect on cell proliferation was determined. RESULTS: Cytotoxicity was found to be highest with TQ and Dox treatments, and cell migration was prevented, especially in the group that received combined TQ and Dox treatment. Moreover, using RT-qPCR analysis, activity in the EGFR and FOXP3 pathway was found to be downregulated the most with TQ, and the amount of protein decreased with TQ and Dox. CONCLUSIONS: The findings showed that the greatest cytotoxic effect and the most apoptosis occurred during TQ treatment. Additionally, it was determined that a significant decrease in EGFR and FOXP3 levels occurred with the application of TQ and Dox.

摘要

目的：通过表皮生长因子受体/叉头框蛋白3（EGFR/FOXP3）信号通路研究阿霉素（Dox）和百里醌（TQ）联合应用对卵巢腺癌细胞（OVCAR3）的细胞毒性和凋亡作用。 方法：我们使用了人OVCAR3细胞和人皮肤角质形成细胞（HaCaT）。将不同浓度的TQ和Dox作用于细胞24、48和72小时，通过MTT法测定细胞毒性水平。通过定量逆转录聚合酶链反应（RT-qPCR）和蛋白质免疫印迹分析确定细胞增殖和凋亡相关的EGFR/FOXP3表达水平。在4',6-二脒基-2-苯基吲哚（DAPI）染色后进行集落计数，确定对细胞增殖的影响。 结果：发现TQ和Dox处理的细胞毒性最高，细胞迁移受到抑制，尤其是在接受TQ和Dox联合处理的组中。此外，使用RT-qPCR分析发现，TQ对EGFR和FOXP3通路的活性下调最为明显，且TQ和Dox处理后蛋白质含量降低。 结论：研究结果表明，TQ处理期间细胞毒性作用最强，凋亡现象最明显。此外，确定TQ和Dox联合应用后EGFR和FOXP3水平显著降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/81228f6fc55c/1678-2674-acb-40-e401725-gf10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/1bf11647010e/1678-2674-acb-40-e401725-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/857d0f425f98/1678-2674-acb-40-e401725-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/d971df5d2ed5/1678-2674-acb-40-e401725-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/abdbe35b73c6/1678-2674-acb-40-e401725-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/a9c31954ac9a/1678-2674-acb-40-e401725-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/e674b0f6ed98/1678-2674-acb-40-e401725-gf06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/d6376648a0c5/1678-2674-acb-40-e401725-gf07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/2d10ea545b65/1678-2674-acb-40-e401725-gf08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/e6e4518130d1/1678-2674-acb-40-e401725-gf09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/81228f6fc55c/1678-2674-acb-40-e401725-gf10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/1bf11647010e/1678-2674-acb-40-e401725-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/857d0f425f98/1678-2674-acb-40-e401725-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/d971df5d2ed5/1678-2674-acb-40-e401725-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/abdbe35b73c6/1678-2674-acb-40-e401725-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/a9c31954ac9a/1678-2674-acb-40-e401725-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/e674b0f6ed98/1678-2674-acb-40-e401725-gf06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/d6376648a0c5/1678-2674-acb-40-e401725-gf07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/2d10ea545b65/1678-2674-acb-40-e401725-gf08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/e6e4518130d1/1678-2674-acb-40-e401725-gf09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261e/11960576/81228f6fc55c/1678-2674-acb-40-e401725-gf10.jpg

相似文献

[1]
Investigation of the effect of thymoquinone and doxorubicin on the EGFR/FOXP3 signaling pathway in OVCAR3 human ovarian adenocarcinoma cells.

Acta Cir Bras. 2025-3-31

[2]
Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the EGFR pathway.

Acta Cir Bras. 2024

[3]
Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling.

Chem Biol Drug Des. 2024-8

[4]
Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.

Mutat Res. 2010-10-30

[5]
Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms.

Life Sci. 2019-7-3

[6]
Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma.

Life Sci. 2020-5-15

[7]
Apoptotic effect of thymoquinone on OVCAR3 cells via the P53 and CASP3 activation.

Acta Cir Bras. 2024

[8]
Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity and the underlying mechanism.

Toxicol Appl Pharmacol. 2025-2

[9]
Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways.

World J Gastroenterol. 2024-6-7

[10]
Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.

World J Gastroenterol. 2016-4-28

本文引用的文献

[1]
Modulation of FOXP3 Gene Expression in OVCAR3 Cells Following Rosmarinic Acid and Doxorubicin Exposure.

Pharmaceuticals (Basel). 2024-11-28

[2]
Gallic Acid Induces HeLa Cell Lines Apoptosis via the P53/Bax Signaling Pathway.

Biomedicines. 2024-11-18

[3]
Inhibitory effect of Curcumin on a cervical cancer cell line via the RAS/RAF signaling pathway.

Histol Histopathol. 2025-3

[4]
Antioxidant Actions of Melatonin: A Systematic Review of Animal Studies.

Antioxidants (Basel). 2024-4-7

[5]
Transient loss of Polycomb components induces an epigenetic cancer fate.

Nature. 2024-5

[6]
Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study.

Cancers (Basel). 2023-8-26

[7]
Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.

Cancer Chemother Pharmacol. 2023-7

[8]
Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?

Biomedicines. 2022-8-29

[9]
Therapeutic implications and clinical manifestations of thymoquinone.

Phytochemistry. 2022-8

[10]
Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway.

Chin Med J (Engl). 2021-12-22

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索